AEON Biopharma President and CEO Robert E. Bancroft Reports Acquisition of $19,590.0238 in Common Shares

PUBT · 14h ago
AEON Biopharma President and CEO Robert E. Bancroft Reports Acquisition of $19,590.0238 in Common Shares
  • AEON Biopharma President and CEO Robert E. Bancroft purchased 152,333 shares of Class A Common Stock.
  • The purchase price was $0.1286 per share, bringing his direct holdings to 3,329,436 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002066370-26-000002), on November 20, 2026, and is solely responsible for the information contained therein.